참고문헌
- CLSI. Defining, establishing and verifying reference intervals in the clinical laboratory; approved guideline, 3rd edition. CLSI document CA28-A3. 2008. Clinical and Laboratory Standards Institute, Wayne, Pennsylbania.
- Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinolysis. 2005,16:597-605. https://doi.org/10.1097/01.mbc.0000187250.32630.56
- Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol. 1992,2:481-94. https://doi.org/10.1016/1047-2797(92)90098-B
- Fourel V, Gabastou JM, Desroys du Roure F, Ehrhardt N, Robert A. Influence of age, sex and ABO blood group on activated partial thromboplastin time. Haemostasis. 1993,23:321-326.
- Gausman JN, Malar RA. Unaccuracy of a "spiked curve" for monitoring UFH therapy. Am J Clin Pathol. 2011,135:870-876. https://doi.org/10.1309/AJCP60ZGXCJKRMJO
- Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987,69:1691-1695. https://doi.org/10.1182/blood.V69.6.1691.1691
- Jang JH, Seo JY, Bang SH, Park IA, Kim HJ, Kim SH. Establishment of reference intervals for von Willebrand factor antigen and eight coagulation factors in a Korean population following the Clinical and Laboratory Standards Institute guidelines. Blood Coagul Fibrinolysis. 2010,21:251-255. https://doi.org/10.1097/MBC.0b013e3283367931
- Jeremic M, Weister O, Gedde-Dahl TW. Factor VIII(AHG) levels in 1016 regular blood donors: The effects of age, sex, and ABO blood groups. Scand J Clin Lab Invest. 1976,36:461-466. https://doi.org/10.3109/00365517609054464
- Kim MJ, Lee AN, Song KS, Kim YJ, Shim AS. Influence of Age, Sex and ABO Blood Group on Activated Partial Thromboplastin Time (APTT). Korean J Hemosat Thromb. 1995,2:155-159.
- Kitchen S, Jennings I, Woods TAL, Preston FE. Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage. J Clin Pathol. 1996,49:10-4. https://doi.org/10.1136/jcp.49.1.10
- Koo BK, Kwon EH, Ryu KH, Yun JW, Kim HJ. Comparison of Two Methods for Heparin Sensitivity; Activated Partial Thromboplastin Time Assay using in vitro Heparin-spiked Sample and Anti-Xa Assay using in vivo Heparin-treated Sample. Korean J Clin Lab Sci. 2011,43:133-137
- Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J Lab Clin Med. 1953,41:637-647.
- Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997,97:775-84. https://doi.org/10.1046/j.1365-2141.1997.1222936.x
- Mari D, Coppola R, Provenzano R. Hemostasis factors and aging. Exp Gerontol. 2008,43:66-73. https://doi.org/10.1016/j.exger.2007.06.014
- McCallum CJ, Peake IR, Newcombe RG, Bloom AL. Factor VIII levels and blood group antigens. Thromb Haemost. 1983,50:757. https://doi.org/10.1055/s-0038-1665305
- McLellan DS, Knight SR, Aronstam A. The relationship between coagulation factor VIII and ABO blood group status. Med Lab Sci. 1988,45:131-134.
- Moellera A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion. 2001,41:56-60. https://doi.org/10.1046/j.1537-2995.2001.41010056.x
- O'Donnell JS, McKinnon TA, Crawley JT, Lane DA, Laffan MA. Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis. Blood. 2005,106:1988-1991.
- Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and Factor in a twin population: Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet. 1985,37:89-101.
- Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. II. The effects of age, sex and blood group. Br J Haematol. 1964,10:238-245. https://doi.org/10.1111/j.1365-2141.1964.tb00698.x
- Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961,36:212-219. https://doi.org/10.1093/ajcp/36.3.212
- Ross JW, Fraser MD, Moore TD. Analytic clinical laboratory precision: state of the art for thirty-one analysis. Am J Clin Pathol. 1980,74:521-530.
- Shetty S, Ghosh K, Mohanty D. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer. Blood Coagul Fibrinolysis. 2003,14:493-497. https://doi.org/10.1097/00001721-200307000-00011
- Souto JC, Almasy L, Muniz-Diaz E, Soria JM, Borrell M, Bayen L, et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol. 2000,20:2024-2028. https://doi.org/10.1161/01.ATV.20.8.2024
- Sukhu K, Poovalingam V, Mahomed R, Giangrande PL. Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease. Clin Lab Haematol. 2003,25:247-9. https://doi.org/10.1046/j.1365-2257.2003.00523.x
피인용 문헌
- A Comparative Study of Rutin and Rutin Glycoside: Antioxidant Activity, Anti-Inflammatory Effect, Effect on Platelet Aggregation and Blood Coagulation vol.10, pp.11, 2015, https://doi.org/10.3390/antiox10111696